Dupixent Lawsuit in North Dakota - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

North Dakota's 6-year statute of limitations — tied with Maine as the longest in the nation for personal injury — provides Dupixent CTCL patients with extraordinary filing flexibility. An estimated 5,500 North Dakotans have been prescribed Dupixent since 2017, primarily through Sanford Health (Fargo/Bismarck) and Altru Health System (Grand Forks). North Dakota lacks an NCI-designated cancer center, and patients requiring specialized CTCL evaluation are typically referred to the University of Minnesota's Masonic Cancer Center in Minneapolis or the Mayo Clinic in Rochester. The District of North Dakota handles minimal pharmaceutical litigation, and most complex cases will benefit from MDL coordination. North Dakota's small, rural population creates limited total claimant volume, but the state's generous SOL ensures no claim expires prematurely. The oil boom-driven population growth in western North Dakota has expanded the state's medical infrastructure but specialist dermatology remains concentrated in the eastern cities.

Written By

People's Justice Legal Research Team

Statute of Limitations

North Dakota: 6 years for product liability (N.D. Cent. Code § 28-01-16). Discovery rule applies — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to the product.

6 years from discovery of injury

Filing Venue

Where to File in North Dakota

North Dakota has a single federal judicial district — the District of North Dakota, with courthouses in Fargo, Bismarck, and Grand Forks. North Dakota follows a modified comparative fault system (50 percent bar) and does not cap compensatory damages in product liability cases. The state's 6-year SOL is among the longest in the nation.

North Dakota Data

Exposure in North Dakota

Source: IQVIA prescription data estimates

Source: N.D. Cent. Code § 28-01-16

Source: National Cancer Institute

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview